norethindrone acetate has been researched along with Syndrome in 2 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Type 2 diabetes and metabolic syndrome are major cardiovascular risk factors in postmenopausal women, but the role of vasoconstrictive endothelin-1 (ET-1) in these conditions is not known." | 5.09 | Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy. ( Puolakka, J; Saltevo, J; Ylikorkala, O, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanchev, S | 1 |
| Slaveĭkov, S | 1 |
| Saltevo, J | 1 |
| Puolakka, J | 1 |
| Ylikorkala, O | 1 |
2 trials available for norethindrone acetate and Syndrome
| Article | Year |
|---|---|
[A clinical study of the efficacy of and tolerance for the combined transdermal preparation Estracomb TTS (CIBA)].
Topics: Administration, Cutaneous; Drug Combinations; Drug Tolerance; Estradiol; Estrogen Replacement Therap | 1997 |
Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Biomarkers; Body Constitution; Body Mass Index; Cho | 2000 |